These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 17710547)
1. Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver. Ackerman Z; Oron-Herman M; Rosenthal T; Pappo O; Link G; Sela BA; Grozovski M Dig Dis Sci; 2008 Mar; 53(3):777-84. PubMed ID: 17710547 [TBL] [Abstract][Full Text] [Related]
2. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Ackerman Z; Oron-Herman M; Grozovski M; Rosenthal T; Pappo O; Link G; Sela BA Hypertension; 2005 May; 45(5):1012-8. PubMed ID: 15824194 [TBL] [Abstract][Full Text] [Related]
3. Effects of antihypertensive and triglyceride lowering agents on splenocyte apoptosis in rats with fatty liver. Ackerman Z; Grozovski M; Oron-Herman M; Rosenthal T; Sela BA; Amir G Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):37-42. PubMed ID: 23489555 [TBL] [Abstract][Full Text] [Related]
4. Effects of antihypertensive and triglyceride-lowering agents on hepatic copper concentrations in rats with fatty liver disease. Ackerman Z; Skarzinski G; Grozovski M; Oron-Herman M; Sela BA Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):545-51. PubMed ID: 24975050 [TBL] [Abstract][Full Text] [Related]
5. Risk reduction therapy for syndrome X: comparison of several treatments. Oron-Herman M; Sela BA; Rosenthal T Am J Hypertens; 2005 Mar; 18(3):372-8. PubMed ID: 15797656 [TBL] [Abstract][Full Text] [Related]
6. Hepatic effects of rosiglitazone in rats with the metabolic syndrome. Ackerman Z; Oron-Herman M; Pappo O; Peleg E; Safadi R; Schmilovitz-Weiss H; Grozovski M Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):663-8. PubMed ID: 20210788 [TBL] [Abstract][Full Text] [Related]
15. Effects of captopril on the cysteamine-induced duodenal ulcer in the rat. Saghaei F; Karimi I; Jouyban A; Samini M Exp Toxicol Pathol; 2012 May; 64(4):373-7. PubMed ID: 21036019 [TBL] [Abstract][Full Text] [Related]
16. Allylmercaptocaptopril: a new antihypertensive drug. Miron T; Rabinkov A; Peleg E; Rosenthal T; Mirelman D; Wilchek M Am J Hypertens; 2004 Jan; 17(1):71-3. PubMed ID: 14700516 [TBL] [Abstract][Full Text] [Related]
17. Aqueous seed extract of Hunteria umbellata (K. Schum.) Hallier f. (Apocynaceae) palliates hyperglycemia, insulin resistance, dyslipidemia, inflammation and oxidative stress in high-fructose diet-induced metabolic syndrome in rats. Ajiboye TO; Hussaini AA; Nafiu BY; Ibitoye OB J Ethnopharmacol; 2017 Feb; 198():184-193. PubMed ID: 27894971 [TBL] [Abstract][Full Text] [Related]
18. Hypoglycemic and hepatoprotective effects of D-chiro-inositol-enriched tartary buckwheat extract in high fructose-fed mice. Hu Y; Zhao Y; Ren D; Guo J; Luo Y; Yang X Food Funct; 2015 Dec; 6(12):3760-9. PubMed ID: 26412138 [TBL] [Abstract][Full Text] [Related]
19. Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats. Si X; Webb RC; Richey JM Can J Physiol Pharmacol; 1999 Oct; 77(10):755-62. PubMed ID: 10588479 [TBL] [Abstract][Full Text] [Related]